• column
  • column
    • Home
    • About Us
      • Our vision
      • Our team
      • Our founders
      • News & Resources
      • Case Studies
      • Clients
      • Advisory board
  • column
    • Our Services
      • How we work
      • Project partners
    • Preclinical Research Services
    • Clinical Trial Volunteer Opportunities
    • Clinical Trials Services
  • column
    • Contact
      • Companies
      • Volunteers
    • FOLLOW US
      • X
      • Linkedin
      • Facebook
Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

by Virtus | Nov 3, 2019

Click the button below to read more about this. CLICK HERE FOR...
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Role of deficient type III interferon-lambda production in asthma exacerbations.

Role of deficient type III interferon-lambda production in asthma exacerbations.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Next Entries »

Recent Posts

  • Preclinical Efficacy Testing in Respiratory Drug Development
  • Outsourcing vs In-House Respiratory Research: Which Approach Is Right for Preclinical Drug Development?
  • Viral Challenge Preclinical Studies in Respiratory Drug Development
  • Respiratory CRO in the UK: How to Evaluate Preclinical Respiratory Research Partners
  • Asthma vs COPD Preclinical Models in Respiratory Drug Development

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact